Literature DB >> 26040207

Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations.

Kouyuki Hirayasu1, Hisashi Arase1,2.   

Abstract

Human leukocyte immunoglobulin-like receptors (LILR) are a family of 11 functional genes encoding five activating (LILRA1, 2, 4-6), five inhibitory (LILRB1-5) and one soluble (LILRA3) form. The number of LILR genes is conserved among individuals, except for LILRA3 and LILRA6, which exhibit copy-number variations. The LILR genes are rapidly evolving and showing large interspecies differences, making it difficult to analyze the functions of LILR using an animal model. LILRs are expressed on various cells such as lymphoid and myeloid cells and the expression patterns are different from gene to gene. The LILR gene expression and polymorphisms have been reported to be associated with autoimmune and infectious diseases such as rheumatoid arthritis and cytomegalovirus infection. Although human leukocyte antigen (HLA) class I is a well-characterized ligand for some LILRs, non-HLA ligands have been increasingly identified in recent years. LILRs have diverse functions, including the regulation of inflammation, immune tolerance, cell differentiation and nervous system plasticity. This review focuses on the genetic and functional diversity of the LILR family.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26040207     DOI: 10.1038/jhg.2015.64

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  80 in total

Review 1.  Inhibitory ITAMs as novel regulators of immunity.

Authors:  Ulrich Blank; Pierre Launay; Marc Benhamou; Renato C Monteiro
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

2.  Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.

Authors:  Yan Du; Yin Su; Jing He; Yue Yang; Yamei Shi; Yong Cui; Cainan Luo; Xinyu Wu; Xu Liu; Fanlei Hu; Xiaoxu Ma; Li Zheng; Jing Zhang; Xianbo Zuo; Yujun Sheng; Lijun Wu; Xuejun Zhang; Jianping Guo; Zhanguo Li
Journal:  Ann Rheum Dis       Date:  2014-06-06       Impact factor: 19.103

3.  Killer cell Ig-like receptor-dependent signaling by Ig-like transcript 2 (ILT2/CD85j/LILRB1/LIR-1).

Authors:  Sheryl E Kirwan; Deborah N Burshtyn
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

4.  Comparison of chimpanzee and human leukocyte Ig-like receptor genes reveals framework and rapidly evolving genes.

Authors:  F Canavez; N T Young; L A Guethlein; R Rajalingam; S I Khakoo; B P Shum; P Parham
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

5.  Use of genetic profiling in leprosy to discriminate clinical forms of the disease.

Authors:  Joshua R Bleharski; Huiying Li; Christoph Meinken; Thomas G Graeber; Maria-Teresa Ochoa; Masahiro Yamamura; Anne Burdick; Euzenir N Sarno; Manfred Wagner; Martin Röllinghoff; Thomas H Rea; Marco Colonna; Steffen Stenger; Barry R Bloom; David Eisenberg; Robert L Modlin
Journal:  Science       Date:  2003-09-12       Impact factor: 47.728

6.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

7.  Functional genetic polymorphisms in ILT3 are associated with decreased surface expression on dendritic cells and increased serum cytokines in lupus patients.

Authors:  Mark A Jensen; Karen C Patterson; Akaash A Kumar; Marissa Kumabe; Beverly S Franek; Timothy B Niewold
Journal:  Ann Rheum Dis       Date:  2012-08-17       Impact factor: 19.103

8.  Long-term persistence of both functional and non-functional alleles at the leukocyte immunoglobulin-like receptor A3 (LILRA3) locus suggests balancing selection.

Authors:  Kouyuki Hirayasu; Jun Ohashi; Koichi Kashiwase; Minoko Takanashi; Masahiro Satake; Katsushi Tokunaga; Toshio Yabe
Journal:  Hum Genet       Date:  2006-02-24       Impact factor: 4.132

9.  Comparative genomics of natural killer cell receptor gene clusters.

Authors:  James Kelley; Lutz Walter; John Trowsdale
Journal:  PLoS Genet       Date:  2005-08       Impact factor: 5.917

10.  A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.

Authors:  M Colonna; F Navarro; T Bellón; M Llano; P García; J Samaridis; L Angman; M Cella; M López-Botet
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

View more
  42 in total

1.  Human immune system diversity and its implications in diseases.

Authors:  Naoyuki Tsuchiya; Jun Ohashi
Journal:  J Hum Genet       Date:  2015-11       Impact factor: 3.172

2.  Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis.

Authors:  Chikashi Terao; Hajime Yoshifuji; Takayoshi Matsumura; Taeko K Naruse; Tomonori Ishii; Yoshikazu Nakaoka; Yohei Kirino; Keitaro Matsuo; Tomoki Origuchi; Masakazu Shimizu; Yasuhiro Maejima; Eisuke Amiya; Natsuko Tamura; Takahisa Kawaguchi; Meiko Takahashi; Kazuya Setoh; Koichiro Ohmura; Ryu Watanabe; Tetsuya Horita; Tatsuya Atsumi; Mitsuru Matsukura; Tetsuro Miyata; Yuta Kochi; Toshio Suda; Kazuo Tanemoto; Akira Meguro; Yukinori Okada; Akiyoshi Ogimoto; Motohisa Yamamoto; Hiroki Takahashi; Shingo Nakayamada; Kazuyoshi Saito; Masataka Kuwana; Nobuhisa Mizuki; Yasuharu Tabara; Atsuhisa Ueda; Issei Komuro; Akinori Kimura; Mitsuaki Isobe; Tsuneyo Mimori; Fumihiko Matsuda
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-29       Impact factor: 11.205

3.  Paired Siglec receptors generate opposite inflammatory responses to a human-specific pathogen.

Authors:  Flavio Schwarz; Corinna S Landig; Shoib Siddiqui; Ismael Secundino; Joshua Olson; Nissi Varki; Victor Nizet; Ajit Varki
Journal:  EMBO J       Date:  2017-01-18       Impact factor: 11.598

Review 4.  The state of play in higher eukaryote gene annotation.

Authors:  Jonathan M Mudge; Jennifer Harrow
Journal:  Nat Rev Genet       Date:  2016-10-24       Impact factor: 53.242

Review 5.  Leukocyte immunoglobulin-like receptors in human diseases: an overview of their distribution, function, and potential application for immunotherapies.

Authors:  Jilu Zhang; Sunny Mai; Hui-Ming Chen; Kyeongah Kang; Xian Chang Li; Shu-Hsia Chen; Ping-Ying Pan
Journal:  J Leukoc Biol       Date:  2017-03-28       Impact factor: 4.962

6.  Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development.

Authors:  Xun Gui; Mi Deng; Hao Song; Yuanzhi Chen; Jingjing Xie; Zunling Li; Licai He; Fangfang Huang; Yixiang Xu; Yasuaki Anami; Hai Yu; Chenyi Yu; Leike Li; Zihao Yuan; Xiaoying Xu; Qihui Wang; Yan Chai; Tao Huang; Yi Shi; Kyoji Tsuchikama; X Charlene Liao; Ningshao Xia; George F Gao; Ningyan Zhang; Cheng Cheng Zhang; Zhiqiang An
Journal:  Cancer Immunol Res       Date:  2019-06-18       Impact factor: 11.151

Review 7.  Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling.

Authors:  Bochra Tourki; Ganesh Halade
Journal:  FASEB J       Date:  2017-06-22       Impact factor: 5.191

Review 8.  Immunoglobulin-like receptors and the generation of innate immune memory.

Authors:  Mouhamad Al-Moussawy; Hossam A Abdelsamed; Fadi G Lakkis
Journal:  Immunogenetics       Date:  2022-01-16       Impact factor: 2.846

9.  Microbially cleaved immunoglobulins are sensed by the innate immune receptor LILRA2.

Authors:  Kouyuki Hirayasu; Fumiji Saito; Tadahiro Suenaga; Kyoko Shida; Noriko Arase; Keita Oikawa; Toshifumi Yamaoka; Hiroyuki Murota; Hiroji Chibana; Ichiro Nakagawa; Tomoko Kubori; Hiroki Nagai; Yuji Nakamaru; Ichiro Katayama; Marco Colonna; Hisashi Arase
Journal:  Nat Microbiol       Date:  2016-04-25       Impact factor: 17.745

10.  Zika Virus Escapes NK Cell Detection by Upregulating Major Histocompatibility Complex Class I Molecules.

Authors:  Ariella Glasner; Esther Oiknine-Djian; Yiska Weisblum; Mohammad Diab; Amos Panet; Dana G Wolf; Ofer Mandelboim
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.